Vera-App für Wechseljahresbeschwerden

DiGA App for Menopause · provisionally listed

Vera-App für Wechseljahresbeschwerden App at a Glance

🇩🇪 Legally binding original Rechtsverbindliches Original · BfArM

Die Vera-App unterstützt Patientinnen mit Wechseljahres-Beschwerden durch evidenzbasierte und leitlinienkonforme Inhalte, Methoden und Übungen der multimodalen Behandlung von Wechseljahres-Beschwerden. Die Vera-App richtet sich an Betroffene mit mindestens mittelschweren Wechseljahres-Beschwerden, für die die Diagnose „Zustände im Zusammenhang mit der Menopause und dem Klimakterium (N95.1)“ vorliegt. Mittelschwere Wechseljahres-Beschwerden liegen vor, wenn auf der Menopause Rating Scale (MRS-II) mindestens 9 Punkte erreicht werden.Allgemeine Kontraindikationen sind nicht angegeben. Die Vera-App ist eine Smartphone-Anwendung, die Patientinnen Selbstmanagement-Strategien vermittelt und als Begleittherapie zu anderen Therapien im Rahmen der Standardversorgung eingesetzt werden kann. Zudem kann sie im Rahmen der Tertiären Prävention einer weiteren Verschlechterung der Symptome und Lebensqualität vorbeugen.

🇬🇧 English translation automatically translated

The Vera app supports female patients with menopausal complaints through evidence-based and guideline-compliant content, methods, and exercises for the multimodal treatment of menopausal complaints. The Vera app is aimed at affected individuals with at least moderate menopausal complaints for whom the diagnosis "conditions associated with menopause and the climacteric (N95.1)" has been established. Moderate menopausal complaints are present when a score of at least 9 points is reached on the Menopause Rating Scale (MRS-II). No general contraindications are specified. The Vera app is a smartphone application that teaches female patients self-management strategies and can be used as an adjunctive therapy alongside other therapies within the framework of standard care. In addition, it can be used within the framework of tertiary prevention to prevent further deterioration of symptoms and quality of life.

Automatically translated for informational purposes · Source: BfArM· Updated 9/23/2026

Category

Urogenital

Indicated for

Menopause

Manufacturer

Endo Health GmbH, Deutschland

Listed Since

2026-01-20 - provisionally listed

Help and Support for the Vera-App für Wechseljahresbeschwerden App

Questions about the app, signing in or the activation code are answered by the manufacturer, Endo Health GmbH. We only run this directory and have no access to your app or your account.

Go to Endo Health GmbH support

What are the experiences with the Vera-App für Wechseljahresbeschwerden app?

Apple App Store

4.5 · 119 ratings
Download on the App Store

Google Play Store

3.7 · 119 ratings
Get it on Google Play

Ratings from the Apple App Store or Google Play Store as of 11/8/2026. We do not verify whether they come from people who have actually used the app.

Details

Indicated for ICD-10

  • N95.1Menopausal and female climacteric states

Source: ICD-10 2019 (WHO)

Contraindications

According to the manufacturer, there are no medical contraindications per ICD-10 for this DiGA.

Prescription Period

90 days

PZN

20401095

How much does the Vera-App für Wechseljahresbeschwerden app cost?

Free with statutory health insurance

Health insurance cost: 598.95 EUR for 90 days

Medical Device Risk Class

Risk class I under MDR

Last changed (BfArM)

9/23/2026

Age Group

Adults between 18 and 65 years

Additional Devices

none

Languages

German

Where can I find the Vera-App für Wechseljahresbeschwerden app?

Download on the App StoreGet it on Google Play

FAQ

Find all the answers to your questions about the Vera-App für Wechseljahresbeschwerden app here.